Advertisement
Screener

Tilray Brands, Inc. (TLRY) Finance Lease, Right-of-Use Asset, after Accumulated Amortization

2.3 / 5 stars · 30/64 Roast Me

Tilray Brands, Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization

Tilray Brands, Inc. (TLRY) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $117.98 million as of 2026-05-31, per its 10-K filed 2026-07-28.

Financial Statements › Balance Sheet › Assets › Assets, Noncurrent

us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-07-28

  • 2026-05-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $117.98M.
  • 2026-02-28: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $38.79M.
  • 2025-11-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $39.41M.
  • 2025-08-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $40.02M.
Period endFinance Lease, Right-of-Use Asset, after Accumulated Amortization
2026-05-31$117.98M
10-K · filed 2026-07-28
2026-02-28$38.79M
10-Q · filed 2026-04-01
2025-11-30$39.41M
10-Q · filed 2026-01-08
2025-08-31$40.02M
10-Q · filed 2025-10-09
2025-05-31$40.31M
10-K · filed 2026-07-28
2025-02-28$40.69M
10-Q · filed 2025-04-08
2024-11-30$41.48M
10-Q · filed 2025-01-10
2024-08-31$43.43M
10-Q · filed 2024-10-10
2024-05-31$43.99M
10-K · filed 2025-07-29
2024-02-29$56.23M
10-Q · filed 2024-04-09
2023-11-30$57.06M
10-Q · filed 2024-01-09
2023-05-31$0.00
10-K · filed 2024-07-30
2021-05-31$34.73M
10-K · filed 2022-07-28
2020-12-31$13.17M
10-K · filed 2021-02-19
2019-12-31$13.31M
10-K · filed 2021-02-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87